Serum uric acid as a marker of impaired oxidative metabolism in chronic heart failure

F. Leyva, S. D. Anker, T. P. Chua, I. F. Godsland, J. C. Stevenson, A. J S Coats

Research output: Contribution to journalArticle

Abstract

Elevated serum uric acid concentrations have been observed in clinical conditions associated with hypoxia. Since chronic heart failure (CHF) is a state of unpaired oxidative metabolism, we sought to determine whether serum uric acid concentrations relate to measures of functional capacity and disease severity. Methods: Patients with CHF (n=59) and healthy controls (n=20) underwent assessment of maximal oxygen consumption (MVO2) and regression slope relating to minute ventilation to carbon dioxide output (VE-VCO2) during a maximal treadmill exercise test. A metabolic assessment included measurement of serum uric acid and insulin sensitivity (obtained by minimal modelling analysis of glucose and insulin responses during an intravenous glucose tolerance test). Results: Compared to controls, patients with CHF had a 52% lower MVO2, 56.8% higher serum uric acid concentrations, and a 60.5% lower insulin sensitivity (all p2 (r=-0.50) (both p2 (r=0.45) and NYHA class (r=0.36) (both p2, exercise time (both p2 and NYHA class (both p2 suggests that in CHF, serum uric acid concentrations can provide an index of an impairment of oxidative metabolism.

Original languageEnglish
JournalHeart
Volume77
Issue numberSUPPL. 1
Publication statusPublished - May 1997

Fingerprint

Uric Acid
Heart Failure
Serum
Exercise Test
Insulin Resistance
Glucose Tolerance Test
Carbon Dioxide
Oxygen Consumption
Ventilation
Exercise
Insulin
Glucose

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Leyva, F., Anker, S. D., Chua, T. P., Godsland, I. F., Stevenson, J. C., & Coats, A. J. S. (1997). Serum uric acid as a marker of impaired oxidative metabolism in chronic heart failure. Heart, 77(SUPPL. 1).

Serum uric acid as a marker of impaired oxidative metabolism in chronic heart failure. / Leyva, F.; Anker, S. D.; Chua, T. P.; Godsland, I. F.; Stevenson, J. C.; Coats, A. J S.

In: Heart, Vol. 77, No. SUPPL. 1, 05.1997.

Research output: Contribution to journalArticle

Leyva, F, Anker, SD, Chua, TP, Godsland, IF, Stevenson, JC & Coats, AJS 1997, 'Serum uric acid as a marker of impaired oxidative metabolism in chronic heart failure', Heart, vol. 77, no. SUPPL. 1.
Leyva F, Anker SD, Chua TP, Godsland IF, Stevenson JC, Coats AJS. Serum uric acid as a marker of impaired oxidative metabolism in chronic heart failure. Heart. 1997 May;77(SUPPL. 1).
Leyva, F. ; Anker, S. D. ; Chua, T. P. ; Godsland, I. F. ; Stevenson, J. C. ; Coats, A. J S. / Serum uric acid as a marker of impaired oxidative metabolism in chronic heart failure. In: Heart. 1997 ; Vol. 77, No. SUPPL. 1.
@article{61360a0f703e4e02a2cec7f680a93246,
title = "Serum uric acid as a marker of impaired oxidative metabolism in chronic heart failure",
abstract = "Elevated serum uric acid concentrations have been observed in clinical conditions associated with hypoxia. Since chronic heart failure (CHF) is a state of unpaired oxidative metabolism, we sought to determine whether serum uric acid concentrations relate to measures of functional capacity and disease severity. Methods: Patients with CHF (n=59) and healthy controls (n=20) underwent assessment of maximal oxygen consumption (MVO2) and regression slope relating to minute ventilation to carbon dioxide output (VE-VCO2) during a maximal treadmill exercise test. A metabolic assessment included measurement of serum uric acid and insulin sensitivity (obtained by minimal modelling analysis of glucose and insulin responses during an intravenous glucose tolerance test). Results: Compared to controls, patients with CHF had a 52{\%} lower MVO2, 56.8{\%} higher serum uric acid concentrations, and a 60.5{\%} lower insulin sensitivity (all p2 (r=-0.50) (both p2 (r=0.45) and NYHA class (r=0.36) (both p2, exercise time (both p2 and NYHA class (both p2 suggests that in CHF, serum uric acid concentrations can provide an index of an impairment of oxidative metabolism.",
author = "F. Leyva and Anker, {S. D.} and Chua, {T. P.} and Godsland, {I. F.} and Stevenson, {J. C.} and Coats, {A. J S}",
year = "1997",
month = "5",
language = "English",
volume = "77",
journal = "Heart",
issn = "1355-6037",
publisher = "BMJ Publishing Group",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Serum uric acid as a marker of impaired oxidative metabolism in chronic heart failure

AU - Leyva, F.

AU - Anker, S. D.

AU - Chua, T. P.

AU - Godsland, I. F.

AU - Stevenson, J. C.

AU - Coats, A. J S

PY - 1997/5

Y1 - 1997/5

N2 - Elevated serum uric acid concentrations have been observed in clinical conditions associated with hypoxia. Since chronic heart failure (CHF) is a state of unpaired oxidative metabolism, we sought to determine whether serum uric acid concentrations relate to measures of functional capacity and disease severity. Methods: Patients with CHF (n=59) and healthy controls (n=20) underwent assessment of maximal oxygen consumption (MVO2) and regression slope relating to minute ventilation to carbon dioxide output (VE-VCO2) during a maximal treadmill exercise test. A metabolic assessment included measurement of serum uric acid and insulin sensitivity (obtained by minimal modelling analysis of glucose and insulin responses during an intravenous glucose tolerance test). Results: Compared to controls, patients with CHF had a 52% lower MVO2, 56.8% higher serum uric acid concentrations, and a 60.5% lower insulin sensitivity (all p2 (r=-0.50) (both p2 (r=0.45) and NYHA class (r=0.36) (both p2, exercise time (both p2 and NYHA class (both p2 suggests that in CHF, serum uric acid concentrations can provide an index of an impairment of oxidative metabolism.

AB - Elevated serum uric acid concentrations have been observed in clinical conditions associated with hypoxia. Since chronic heart failure (CHF) is a state of unpaired oxidative metabolism, we sought to determine whether serum uric acid concentrations relate to measures of functional capacity and disease severity. Methods: Patients with CHF (n=59) and healthy controls (n=20) underwent assessment of maximal oxygen consumption (MVO2) and regression slope relating to minute ventilation to carbon dioxide output (VE-VCO2) during a maximal treadmill exercise test. A metabolic assessment included measurement of serum uric acid and insulin sensitivity (obtained by minimal modelling analysis of glucose and insulin responses during an intravenous glucose tolerance test). Results: Compared to controls, patients with CHF had a 52% lower MVO2, 56.8% higher serum uric acid concentrations, and a 60.5% lower insulin sensitivity (all p2 (r=-0.50) (both p2 (r=0.45) and NYHA class (r=0.36) (both p2, exercise time (both p2 and NYHA class (both p2 suggests that in CHF, serum uric acid concentrations can provide an index of an impairment of oxidative metabolism.

UR - http://www.scopus.com/inward/record.url?scp=33750895263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750895263&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750895263

VL - 77

JO - Heart

JF - Heart

SN - 1355-6037

IS - SUPPL. 1

ER -